Chronomics, the epigentic testing company, has raised £1.12M in funding from investors that include SOSV, IndieBio, and Anthemis Group. The company was founded by Charles Ball, Daniel Martin Herranz, Toby Call, and Tom Stubbs in 2017.
Page 8 of 9
